Eck R, Hundt S, Hrtl A, Roemer E, Knkel W
NCT04255433) is expected to provide definitive answers on the impact of tirzepatide on cardiovascular disease compared with dulaglutide, a long-acting GLP-1 RA that has been shown to be cardioprotective in individuals with type 2 diabetes at increased cardiovascular risk [31]
Cardiac causes are classified as structural or arrhythmic, with testing guided by clinical suspicion
Rapid weight loss associated with tirzepatide therapy may contribute to orthostatic hypotensiona drop in blood pressure upon standing
COAs should be lot-specific and from a third-party laboratory, not self-generated by the vendor
You should: Check your blood glucose levels more frequently when initiating berberine, especially if you use insulin or sulfonylureas Recognise hypoglycaemia symptoms (trembling, sweating, confusion, rapid heartbeat, dizziness) and know how to respond appropriately Keep fast-acting carbohydrates available (glucose tablets, fruit juice) to treat low blood sugar promptly Contact your GP or diabetes nurse if you experience recurrent hypoglycaemia, as medication adjustments may be necessary Gastrointestinal symptom monitoring is equally important
